Pharmacogenomics: current status and future perspectives

Pirmohamed, Munir ORCID: 0000-0002-7534-7266 (2023) Pharmacogenomics: current status and future perspectives. NATURE REVIEWS GENETICS, 24 (6). pp. 350-362.

	Text SUPPLEMENTARY DATA_Pirmohamed.docx - Author Accepted Manuscript Download (52kB)
	Text Pirmohamed_v3_CLEAN_1669302241_1_MP_clean.docx - Author Accepted Manuscript Download (344kB)

Abstract

Inter-individual variability in drug response, be it efficacy or safety, is common and likely to become an increasing problem globally given the growing elderly population requiring treatment. Reasons for this inter-individual variability include genomic factors, an area of study called pharmacogenomics. With genotyping technologies now widely available and decreasing in cost, implementing pharmacogenomics into clinical practice - widely regarded as one of the initial steps in mainstreaming genomic medicine - is currently a focus in many countries worldwide. However, major challenges of implementation lie at the point of delivery into health-care systems, including the modification of current clinical pathways coupled with a massive knowledge gap in pharmacogenomics in the health-care workforce. Pharmacogenomics can also be used in a broader sense for drug discovery and development, with increasing evidence suggesting that genomically defined targets have an increased success rate during clinical development.

Item Type:	Article
Uncontrolled Keywords:	Humans, Genomics, Pharmacogenetics, Aged
Divisions:	Faculty of Health and Life Sciences Faculty of Health and Life Sciences > Institute of Systems, Molecular and Integrative Biology
Depositing User:	Symplectic Admin
Date Deposited:	22 May 2023 08:32
Last Modified:	27 Jul 2023 01:30
DOI:	10.1038/s41576-022-00572-8
Related URLs:	Author Publisher
URI:	https://livrepository.liverpool.ac.uk/id/eprint/3170550